Hyperlipidemia, characterized by elevated serum levels of lipids such as cholesterol and triglycerides, is a major modifiable risk factor for cardiovascular diseases (CVDs) and metabolic disorders globally. While the term “hyperlipidemia” does not directly appear in the classical Ayurvedic literature, correlated pathological concepts—particularly Meda Dhatu imbalance and Medovaha Srotodushti—have long been discussed in classical texts. It is a major risk factor for cardiovascular diseases (CVD), metabolic syndrome, and related morbidity/mortality. Modern medicine uses statins and lifestyle modification but these have limitations and side effects. Ayurveda offers traditional conceptualization and management strategies that are being validated by modern research. This research paper synthesizes classical Ayurvedic texts, modern pathophysiological understandings, and recent clinical studies to explore the etiology, pathogenesis, diagnostic approaches, and therapeutic strategies for hyperlipidemia drawing from ancient scriptures like Charaka Samhita, Sushruta Samhita, and Ashtanga Hridaya, alongside contemporary research.
1*Dr. Seema V. Rathod, MD (Kayachikitsa), 2Dr. Gunvant H. Yeola, MD, PhD (Kayachikitsa) (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: